Table 7.
Compounds* | CDK9 (IC50, nM) ATP conc. At Km | CDK9 (IC50, nM) high ATP conc. | Phospho-RNAPolyII Ser2 (IC50, nM) | Caspase activity MV4-11 (IC50, nM) |
---|---|---|---|---|
42 | <3 | <3 | <7 | 13 |
43 | <3 | <4 | 11 | 15 |
44 | <3 | <3 | 10 | 15 |
45 | <3 | <3 | 7 | 10 |
46 | <3 | 9 | 38 | 36 |
CDK: cyclin-dependent kinase; IC50: half maximal inhibitory concentration; Phospho-RNAPolyII: phosphorylated RNA polymerase II. *From the corresponding structures in Figure 6.